These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 24265323)

  • 1. Phosphorylated Akt expression is a prognostic marker in early-stage non-small cell lung cancer.
    Yip PY; Cooper WA; Kohonen-Corish MR; Lin BP; McCaughan BC; Boyer MJ; Kench JG; Horvath LG
    J Clin Pathol; 2014 Apr; 67(4):333-40. PubMed ID: 24265323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
    Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H
    Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High expression of the transcriptional co-activator p300 predicts poor survival in resectable non-small cell lung cancers.
    Hou X; Li Y; Luo RZ; Fu JH; He JH; Zhang LJ; Yang HX
    Eur J Surg Oncol; 2012 Jun; 38(6):523-30. PubMed ID: 22440742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear and cytoplasmic cellular distribution of survivin as survival predictor in resected non-small-cell lung cancer.
    Bria E; Visca P; Novelli F; Casini B; Diodoro MG; Perrone-Donnorso R; Botti C; Sperduti I; Facciolo F; Milella M; Cecere FL; Cognetti F; Mottolese M
    Eur J Surg Oncol; 2008 May; 34(5):593-8. PubMed ID: 17693049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the 7th TNM classification for non-small cell lung cancer: a retrospective analysis on prognostic implications for operated node-negative cases.
    Bergman P; Brodin D; Lewensohn R; de Petris L
    Acta Oncol; 2013 Aug; 52(6):1189-94. PubMed ID: 23215828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
    Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Impact of visceral pleural invasion on the prognosis of stage Ib non-small cell lung cancer].
    Su XD; Long H; Wang X; Fu JH; He JH; Lin P; Zhang LJ; Ma GW
    Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):368-71. PubMed ID: 18953838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correlation of P27 expression and localization to phosphorylated AKT in non-small cell lung cancer].
    Miao LJ; Wang J; Li SS; Wu YM; Wu YJ; Wang XC
    Ai Zheng; 2006 Oct; 25(10):1216-20. PubMed ID: 17059763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphatic invasion predicts survival in patients with early node-negative non-small cell lung cancer.
    Nentwich MF; Bohn BA; Uzunoglu FG; Reeh M; Quaas A; Grob TJ; Perez D; Kutup A; Bockhorn M; Izbicki JR; Vashist YK
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):781-7. PubMed ID: 23778087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTEN and phosphorylated AKT expression and prognosis in early- and late-stage non-small cell lung cancer.
    Lim WT; Zhang WH; Miller CR; Watters JW; Gao F; Viswanathan A; Govindan R; McLeod HL
    Oncol Rep; 2007 Apr; 17(4):853-7. PubMed ID: 17342327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of EGFR mutation status on outcomes in patients with resected stage I non-small cell lung cancers.
    Izar B; Sequist L; Lee M; Muzikansky A; Heist R; Iafrate J; Dias-Santagata D; Mathisen D; Lanuti M
    Ann Thorac Surg; 2013 Sep; 96(3):962-8. PubMed ID: 23932319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor for hyaluronic acid-mediated motility (RHAMM, CD168) expression is prognostically important in both nodal negative and nodal positive large cell lung cancer.
    Augustin F; Fiegl M; Schmid T; Pomme G; Sterlacci W; Tzankov A
    J Clin Pathol; 2015 May; 68(5):368-73. PubMed ID: 25731190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer.
    Yang J; Liu H; Wang H; Sun Y
    Pathol Res Pract; 2013 Aug; 209(8):490-4. PubMed ID: 23827213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors after complete resection of pN2 non-small cell lung cancer.
    Sonobe M; Date H; Wada H; Okubo K; Hamakawa H; Teramukai S; Matsumura A; Nakagawa T; Sumitomo S; Miyamoto Y; Okumura N; Takeo S; Kawakami K; Aoki M; Kosaka S;
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):788-95. PubMed ID: 23810113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of MCM7 expression in the bronchial brushings of patients with non-small cell lung cancer (NSCLC).
    Liu YZ; Jiang YY; Hao JJ; Lu SS; Zhang TT; Shang L; Cao J; Song X; Wang BS; Cai Y; Zhan QM; Wang MR
    Lung Cancer; 2012 Jul; 77(1):176-82. PubMed ID: 22456526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of lymphovascular invasion compared with that of visceral pleural invasion in patients with pN0 non-small-cell lung cancer and a tumor diameter of 2 cm or smaller.
    Tao H; Hayashi T; Sano F; Takahagi A; Tanaka T; Matsuda E; Okabe K
    J Surg Res; 2013 Nov; 185(1):250-4. PubMed ID: 23830361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The significance of visceral pleural surface invasion in 321 cases of non-small cell lung cancers with pleural retraction.
    Chang YL; Lin MW; Shih JY; Wu CT; Lee YC
    Ann Surg Oncol; 2012 Sep; 19(9):3057-64. PubMed ID: 22492226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical resection for multifocal (T4) non-small cell lung cancer: is the T4 designation valid?
    Port JL; Korst RJ; Lee PC; Kansler AL; Kerem Y; Altorki NK
    Ann Thorac Surg; 2007 Feb; 83(2):397-400. PubMed ID: 17257959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stage IB nonsmall cell lung cancers: are they all the same?
    Jones DR; Daniel TM; Denlinger CE; Rundall BK; Smolkin ME; Wick MR
    Ann Thorac Surg; 2006 Jun; 81(6):1958-62; discussion 1962. PubMed ID: 16731113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical-pathologic factors affect long-term outcomes in stage IB (pT2 N0 M0) non-small cell lung cancer: a heterogeneous disease.
    Hsu CP; Hsia JY; Chang GC; Chuang CY; Shai SE; Yang SS; Lee MC; Kwan PC
    J Thorac Cardiovasc Surg; 2009 Aug; 138(2):426-33. PubMed ID: 19619791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.